PTGX icon

Protagonist Therapeutics

274 hedge funds and large institutions have $3.15B invested in Protagonist Therapeutics in 2025 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 86 increasing their positions, 90 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
274
Holders Change
+34
Holders Change %
+14.17%
% of All Funds
3.72%
Holding in Top 10
14
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+100%
% of All Funds
0.19%
New
72
Increased
86
Reduced
90
Closed
35
Calls
$51.1M
Puts
$31.9M
Net Calls
+$19.2M
Net Calls Change
+$20M
Name Holding Trade Value Shares
Change
Shares
Change %
FIA
301
FNY Investment Advisers
New York
-$38K -1,000 Closed
HFM
302
Harvest Fund Management
China
-$3K -80 Closed
Group One Trading
303
Group One Trading
Illinois
-$2.7K -70 Closed
AAP
304
Arax Advisory Partners
Colorado
-$811 -21 Closed
Jones Financial Companies
305
Jones Financial Companies
Missouri
-$695 -18 Closed
Federated Hermes
306
Federated Hermes
Pennsylvania
-$270 -7 Closed
IA
307
IFP Advisors
Florida
-$193 -5 Closed
HNB
308
Huntington National Bank
Ohio
-$193 -5 Closed